Zetia Wholesalers Denied Class Cert. In Generics-Delay Suit
A group of wholesalers accusing Merck and Glenmark Pharmaceuticals of a scheme to delay a generic cholesterol drug are unlikely to force a settlement on the companies after a Virginia federal...To view the full article, register now.
Already a subscriber? Click here to view full article